Prevalance of Cesarean Section Niche in Patients With Abnormal Uterine Bleeding

September 23, 2021 updated by: Mahmoud Ramadan Hafez
Prevalance of Cesarean section niche in patients with abnormal uterine bleeding

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Sabry M Mohamed, Professor Dr

Study Locations

  • Egypt
      • Sohag, Egypt
        • Recruiting
        • Sohag University
        • Contact:
          • Osama R Elsherief

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Prevalance of Cesarean section niche in patients with abnormal uterine bleeding

Description

Inclusion Criteria:

Age between 20-40 years old. Non pregnant women. Previous cesarean section (one or more). Presence of abnormal uterine bleeding

Exclusion Criteria:

Virgins Pregnant women. Patients with vaginal delivery. Patients with uterine bleeding with known cause.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cesarean section niche and patients with abnormal uterine bleeding
Observation by Tvs
Other: By TVS
Uses of TVS to diagnosis of Cesarean section niche in patients with abnormal uterine bleeding
Abnormal uterine bleeding in patients without Cesarean section niche
Observation by Tvs
Other: By TVS
Uses of TVS to diagnosis of Cesarean section niche in patients with abnormal uterine bleeding

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cesarean section niche in patients with abnormal uterine bleeding
Time Frame: 6 months
To study relationship between the niche and the abnormal uterine bleeding
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mahmoud Ramadan Hafez

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2021

Primary Completion (Anticipated)

April 1, 2022

Study Completion (Anticipated)

August 1, 2022

Study Registration Dates

First Submitted

September 23, 2021

First Submitted That Met QC Criteria

September 23, 2021

First Posted (Actual)

October 5, 2021

Study Record Updates

Last Update Posted (Actual)

October 5, 2021

Last Update Submitted That Met QC Criteria

September 23, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-Med-21-09-06

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Section Niche and Abnormal Uterine Bleeding

Clinical Trials on By TVS

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe